Charles Schwab Investment Management Inc Gossamer Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,228,077 shares of GOSS stock, worth $859,653. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,228,077

Previous 1,261,597 2.66%

Holding current value

$859,653

Previous $1.14 Million 7.05%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.79 - $1.25 $26,480 - $41,900	-33,520 Reduced 2.66%	1,228,077 $1.22 Million
Q2 2024 Aug 12, 2024	BUY	$0.51 - $1.27 $4,504 - $11,217	8,833 Added 0.71%	1,261,597 $1.14 Million
Q1 2024 May 08, 2024	BUY	$0.8 - $1.51 $26,348 - $49,731	32,935 Added 2.7%	1,252,764 $1.48 Million
Q4 2023 Feb 06, 2024	BUY	$0.48 - $1.08 $66,809 - $150,321	139,187 Added 12.88%	1,219,829 $1.11 Million
Q3 2023 Nov 08, 2023	BUY	$0.78 - $1.82 $508,432 - $1.19 Million	651,837 Added 152.01%	1,080,642 $896,000
Q2 2023 Aug 09, 2023	SELL	$0.98 - $1.53 $33,214 - $51,854	-33,892 Reduced 7.32%	428,805 $514,000
Q1 2023 May 11, 2023	SELL	$0.96 - $2.92 $76,183 - $231,725	-79,358 Reduced 14.64%	462,697 $582,000
Q4 2022 Feb 13, 2023	BUY	$1.74 - $12.87 $20,653 - $152,766	11,870 Added 2.24%	542,055 $1.18 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $957,170 - $1.98 Million	132,756 Added 33.4%	530,185 $6.35 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $60,452 - $100,956	-10,126 Reduced 2.48%	397,429 $3.33 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $143,902 - $212,954	17,050 Added 4.37%	407,555 $3.54 Million
Q4 2021 Feb 11, 2022	BUY	$10.12 - $14.07 $80,332 - $111,687	7,938 Added 2.07%	390,505 $4.42 Million
Q3 2021 Nov 16, 2021	BUY	$7.25 - $13.23 $146,718 - $267,735	20,237 Added 5.59%	382,567 $4.81 Million
Q2 2021 Aug 16, 2021	BUY	$8.0 - $9.75 $338,640 - $412,717	42,330 Added 13.23%	362,330 $2.94 Million
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $148,565 - $188,332	-17,215 Reduced 5.11%	320,000 $2.96 Million
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $5,029 - $8,235	606 Added 0.18%	337,215 $3.26 Million
Q3 2020 Nov 13, 2020	BUY	$11.3 - $14.75 $119,949 - $156,571	10,615 Added 3.26%	336,609 $4.18 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $749,100 - $1.26 Million	78,687 Added 31.82%	325,994 $4.24 Million
Q1 2020 May 15, 2020	BUY	$8.0 - $15.48 $35,992 - $69,644	4,499 Added 1.85%	247,307 $2.51 Million
Q4 2019 Feb 07, 2020	BUY	$14.82 - $26.79 $61,562 - $111,285	4,154 Added 1.74%	242,808 $3.8 Million
Q3 2019 Nov 08, 2019	BUY	$16.02 - $22.47 $2.1 Million - $2.94 Million	131,013 Added 121.71%	238,654 $4.01 Million
Q2 2019 Aug 09, 2019	BUY	$16.12 - $22.89 $360,572 - $512,003	22,368 Added 26.23%	107,641 $2.39 Million
Q1 2019 May 14, 2019	BUY	$17.58 - $23.97 $1.5 Million - $2.04 Million	85,273 New	85,273 $1.85 Million

Others Institutions Holding GOSS

# of Institutions

108

Shares Held

167M

Call Options Held

430K

Put Options Held

519K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $65.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Gossamer Bio, Inc. Transaction History